Apolipoprotein A-I: A Molecule of Diverse Function.

Area of Science:

• Biochemistry
• Immunology
• Oncology

Background:

• Apolipoprotein A-I (apo A-I) is a key structural protein of high-density lipoprotein (HDL).
• It plays crucial roles in reverse cholesterol transport and maintaining cellular cholesterol homeostasis.
• Beyond cardiovascular benefits, apo A-I exhibits diverse functions in immunity and inflammation.

Purpose of the Study:

• To explore the multifaceted roles of apo A-I beyond its established cardiovascular protective functions.
• To investigate the emerging anti-tumor activities of apo A-I in various cancer models.
• To understand the mechanisms underlying apo A-I's potential as an anti-cancer therapeutic agent.

Main Methods:

• Review of existing literature on apo A-I's functions.
• Analysis of studies investigating apo A-I in cancer models (melanoma, lung, ovarian, leukemia, gastric, pancreatic).
• Examination of apo A-I's effects on tumor regression, metastasis, and angiogenesis.

Main Results:

• Apo A-I demonstrates significant anti-tumor activity, including regression of tumor size and reduction of metastasis.
• Its immuno-modulatory effects and ability to clear serum lysophospholipids contribute to anti-cancer actions.
• Apo A-I inhibits tumor-associated neo-angiogenesis and matrix-degrading enzymes involved in metastasis.

Conclusions:

• Apolipoprotein A-I possesses significant anti-tumor potential, extending its therapeutic relevance beyond cardiovascular disease.
• Its mechanisms involve immune modulation, lysophospholipid clearance, and inhibition of angiogenesis and metastasis.
• Further human studies are warranted to fully realize apo A-I's therapeutic efficacy as an anti-cancer agent.